Skip to content

Reentry Incentives and Support for Engagement With Contingency Management

Enhancing Medication for Opioid Use Disorder Retention With Post-Release Contingency Management

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07322588
Acronym
RISE-CM
Enrollment
75
Registered
2026-01-07
Start date
2026-01-01
Completion date
2027-06-30
Last updated
2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder

Keywords

contingency management, opioid use disorder, incarceration, reentry

Brief summary

People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community. In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions. Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD. The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.

Interventions

OTHERReentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention

Participants receive gift card rewards for attending MOUD appointments and counseling appointments after release from incarceration.

Sponsors

Clatsop Behavioral Healthcare
CollaboratorUNKNOWN
Oregon Health Authority
CollaboratorOTHER
Clatsop County Corrections
CollaboratorUNKNOWN
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be adults (age ≥18 years) currently incarcerated at Clatsop County Jail * Be enrolled in the jail's MOUD program at the time of recruitment * Plan to continue MOUD with Clatsop Behavioral Healthcare upon release * Speak English and be able to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Number of patients receiving medication for opioid use disorder1, 2, and 3 monthsWe will assess patient reported receipt of medication for opioid use disorder and also use chart review to determine whether patients are receiving medications and three different time points.

Secondary

MeasureTime frameDescription
Number of contingency management sessions attended3 monthsNumber of contingency management sessions attended per participant
Total contingency management rewards earned3 monthsTotal dollar amount of contingency management rewards earned by participant throughout the intervention
Addiction SeverityBaseline and 3 monthsParticipant reported addiction severity using the validated Brief Addiction Monitor, a 17-item, multidimensional progress monitoring tool designed to support the provision of measurement-based care to patients commencing and matriculating through treatment for substance use disorders (SUD). The BAM items assess: (1) Risk for relapse or worsening severity of SUD (Range 0-180 with higher scores indicating higher risk), (2) Protective behaviors that support recovery and resistance to relapse (Range 0-180 with higher score indicating higher protective factors), and (3) Use of alcohol and other substances (Range 0-90 with higher score indicating higher substance use).
Recovery CapitalBaseline and 3 monthsParticipant reported survey on recovery capital using the validated Brief Assessment of Recovery Capital (BARC-10) survey. Score range 10-60 with higher scores indicating higher recovery capital.

Countries

United States

Contacts

Primary ContactCarol DeFrancesco Senior Research Associate
defrance@ohsu.edu5033105036
Backup ContactLinda Peng, MD
pengli@ohsu.edu5034941801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026